Sonoma Pharmaceuticals (SNOA) Stock Price, Quote, News & History

Q: What sector and industry does Sonoma Pharmaceuticals (SNOA) operate in?

Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Sonoma Pharmaceuticals Inc (SNOA) Stock Price, Quote, News & History

SNOANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$3.03

-0.03-0.98%

At close: Feb 6, 4:00 PM EST

$2.96

-0.07-2.31%

After Hours: Feb 6, 9:25 AM EST

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$3.00

$3.03

Volume / Avg.

17.29K / 19.72K

Day Range

$2.91 - $3.16

52 Wk Range

1.75 - 6.92

Market Cap

$5.04M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.19%

Days to Cover

1.64

Recent Sonoma Pharmaceuticals Inc News

5 Healthcare Stocks On Fire This Week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

Rishabh Mishra

Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results

Avi Kapoor

Why Xos Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.18M

Investing Cash Flow (TTM)

-165.00K

Financing Cash Flow (TTM)

830.00K

Free Cash Flow (TTM)

-2.35M

Capital Expenditure (TTM)

-165.00K

Net Change in Cash (TTM)

-1.52M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.65M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.29

PB Ratio (TTM)

1.37

Earnings Yield % (TTM)

-65.90%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.23

Company Debt

Total Debt

$56.00K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.04M

Debt to Equity

0.14

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$327.00K

Key Statistics

Open

$3.00

$3.03

Volume / Avg.

17.29K / 19.72K

Day Range

$2.91 - $3.16

52 Wk Range

1.75 - 6.92

Market Cap

$5.04M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.19%

Days to Cover

1.64

About

Sector

Health Care

Industry

Pharmaceuticals

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sonoma Pharmaceuticals (SNOA) stock?

You can purchase shares of Sonoma Pharmaceuticals (NASDAQ:SNOA) through any online brokerage.

View our list of the best stock brokerages

Who are Sonoma Pharmaceuticals (SNOA) competitors?

Other companies in Sonoma Pharmaceuticals’s space includes: Gelteq Ltd (NASDAQ:GELS), 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP), Addex Therapeutics Ltd (NASDAQ:ADXN), Kiora Pharmaceuticals Inc (NASDAQ:KPRX) and InMed Pharmaceuticals Inc (NASDAQ:INM).

What is the forecast, or price target, for Sonoma Pharmaceuticals (SNOA) stock?

Sonoma Pharmaceuticals has a consensus price target of $3.25.

What is the current price for Sonoma Pharmaceuticals (SNOA)?

The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $2.96 last updated February 6, 2026 at 9:25 AM EST.

Does Sonoma Pharmaceuticals (SNOA) pay a dividend?

There are no upcoming dividends for Sonoma Pharmaceuticals.

When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?

Sonoma Pharmaceuticals does not have any upcoming earnings scheduled.

Is Sonoma Pharmaceuticals (SNOA) going to split?

There is no upcoming split for Sonoma Pharmaceuticals.

What sector and industry does Sonoma Pharmaceuticals (SNOA) operate in?

Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Gelteq Ltd

NASDAQ:GELS

$0.81

60 Degrees Pharmaceuticals Inc

NASDAQ:SXTP

$4.01

-3.49%

Addex Therapeutics Ltd

NASDAQ:ADXN

$7.50

-5.06%

Kiora Pharmaceuticals Inc

NASDAQ:KPRX

$2.19

1.86%

InMed Pharmaceuticals Inc

Redhill Biopharma Ltd

NASDAQ:RDHL

$1.12

4.67%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$3.00

$3.03

Volume / Avg.

17.29K / 19.72K

Day Range

$2.91 - $3.16

52 Wk Range

1.75 - 6.92

Market Cap

$5.04M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.19%

Days to Cover

1.64

Recent Sonoma Pharmaceuticals Inc News

5 Healthcare Stocks On Fire This Week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

Rishabh Mishra

Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results

Avi Kapoor

Why Xos Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.18M

Investing Cash Flow (TTM)

-165.00K

Financing Cash Flow (TTM)

830.00K

Free Cash Flow (TTM)

-2.35M

Capital Expenditure (TTM)

-165.00K

Net Change in Cash (TTM)

-1.52M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.65M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.29

PB Ratio (TTM)

1.37

Earnings Yield % (TTM)

-65.90%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.23

Company Debt

Total Debt

$56.00K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.04M

Debt to Equity

0.14

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$327.00K

Key Statistics

Open

$3.00

$3.03

Volume / Avg.

17.29K / 19.72K

Day Range

$2.91 - $3.16

52 Wk Range

1.75 - 6.92

Market Cap

$5.04M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.19%

Days to Cover

1.64

About

Sector

Health Care

Industry

Pharmaceuticals

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry